| 1 | [SID47201770] | Active | EC50 | 0.68 | Luminescence Cell-Based/Microorganism Dose Confirmation HTS to Identify Inhibitors of T.Cruzi Replication. [AID2044, Type: confirmatory] | |  View X | Row No. | 1 | | Structure |
| | Substance | | | SID | 47201770 | | CID | 23724261 | | Outcome | Active | | EC50 | 0.68 [uM] | | BioAssay | Luminescence Cell-Based/Microorganism Dose Confirmation HTS to Identify Inhibitors of T.Cruzi Replication. | | AID | 2044 | | BioAssay type | confirmatory | | Target | | | PubMed | | | Data Table |  |
|
| 2 | [SID47201770] | Active | EC50 | 1.02 | Dose Response Confirmation Screen via Multiplex HTS Assay for Inhibitors of MEK Kinase PB1 Domains, specifically MEK5 binding to MEK Kinase 2 Mutant [AID1895, Type: confirmatory] | mitogen-activated protein kinase kinase kinase kinase 2 [Homo sapiens] [gi:22035600] |  View X | Row No. | 2 | | Structure |
| | Substance | | | SID | 47201770 | | CID | 23724261 | | Outcome | Active | | EC50 | 1.02 [uM] | | BioAssay | Dose Response Confirmation Screen via Multiplex HTS Assay for Inhibitors of MEK Kinase PB1 Domains, specifically MEK5 binding to MEK Kinase 2 Mutant | | AID | 1895 | | BioAssay type | confirmatory | | Target | mitogen-activated protein kinase kinase kinase kinase 2 [Homo sapiens] [gi:22035600] | | PubMed | | | Data Table |  |
|
| 3 | [SID47201770] | Active | EC50 | 1.02 | Dose Response Confirmation Screen via Multiplex HTS Assay for Inhibitors of MEK Kinase PB1 Domains, specifically MEK5 binding to MEK Kinase 2 Mutant [AID1895, Type: confirmatory] | mitogen-activated protein kinase kinase kinase kinase 2 [Homo sapiens] [gi:22035600] |  View X | Row No. | 3 | | Structure |
| | Substance | | | SID | 47201770 | | CID | 23724261 | | Outcome | Active | | EC50 | 1.02 [uM] | | BioAssay | Dose Response Confirmation Screen via Multiplex HTS Assay for Inhibitors of MEK Kinase PB1 Domains, specifically MEK5 binding to MEK Kinase 2 Mutant | | AID | 1895 | | BioAssay type | confirmatory | | Target | mitogen-activated protein kinase kinase kinase kinase 2 [Homo sapiens] [gi:22035600] | | PubMed | | | Data Table |  |
|
| 4 | [SID47201770] | Active | Potency | 1.0323 | qHTS for Inhibitors of human tyrosyl-DNA phosphodiesterase 1 (TDP1): qHTS in cells in absence of CPT [AID686978, Type: confirmatory] | |  View X | Row No. | 4 | | Structure |
| | Substance | | | SID | 47201770 | | CID | 23724261 | | Outcome | Active | | Potency | 1.0323 [uM] | | BioAssay | qHTS for Inhibitors of human tyrosyl-DNA phosphodiesterase 1 (TDP1): qHTS in cells in absence of CPT | | AID | 686978 | | BioAssay type | confirmatory | | Target | | | PubMed | | | Data Table |  |
|
| 5 | [SID47201770] | Active | EC50 | 1.29 | A cytotoxicity screen of small molecule inhibitors of the PhoP regulon in Salmonella typhi identified in the primary screen [AID2252, Type: confirmatory] | |  View X | Row No. | 5 | | Structure |
| | Substance | | | SID | 47201770 | | CID | 23724261 | | Outcome | Active | | EC50 | 1.29 [uM] | | BioAssay | A cytotoxicity screen of small molecule inhibitors of the PhoP regulon in Salmonella typhi identified in the primary screen | | AID | 2252 | | BioAssay type | confirmatory | | Target | | | PubMed | | | Data Table |  |
|
| 6 | [SID47201770] | Active | Potency | 1.636 | qHTS for Inhibitors of human tyrosyl-DNA phosphodiesterase 1 (TDP1): qHTS in cells in presence of CPT [AID686979, Type: confirmatory] | |  View X | Row No. | 6 | | Structure |
| | Substance | | | SID | 47201770 | | CID | 23724261 | | Outcome | Active | | Potency | 1.636 [uM] | | BioAssay | qHTS for Inhibitors of human tyrosyl-DNA phosphodiesterase 1 (TDP1): qHTS in cells in presence of CPT | | AID | 686979 | | BioAssay type | confirmatory | | Target | | | PubMed | | | Data Table |  |
|
| 7 | [SID47201770] | Active | AC50 | 2.158 | Luminescence Cell-Based Dose Retest to Confirm Inhibitors of Beta Cell Apoptosis [AID449756, Type: confirmatory] | |  View X | Row No. | 7 | | Structure |
| | Substance | | | SID | 47201770 | | CID | 23724261 | | Outcome | Active | | AC50 | 2.158 [uM] | | BioAssay | Luminescence Cell-Based Dose Retest to Confirm Inhibitors of Beta Cell Apoptosis | | AID | 449756 | | BioAssay type | confirmatory | | Target | | | PubMed | | | Data Table |  |
|
| 8 | [SID47201770] | Active | AC50 | 3.011 | Fluorescence Cell-Free Homogeneous Secondary Screen to Identify Inhibitors of DnaB-Intein Splicing Activity [AID449749, Type: confirmatory] | replicative DNA helicase [Mycobacterium tuberculosis H37Rv] [gi:15607200] |  View X | Row No. | 8 | | Structure |
| | Substance | | | SID | 47201770 | | CID | 23724261 | | Outcome | Active | | AC50 | 3.011 [uM] | | BioAssay | Fluorescence Cell-Free Homogeneous Secondary Screen to Identify Inhibitors of DnaB-Intein Splicing Activity | | AID | 449749 | | BioAssay type | confirmatory | | Target | replicative DNA helicase [Mycobacterium tuberculosis H37Rv] [gi:15607200] | | PubMed | | | Data Table |  |
|
| 9 | [SID47201770] | Active | AC50 | 3.218 | ATP-based Luminescence in the Absence of Cytokines Measured in Cell-Based System Using Plate Reader - 2061-06_Inhibitor_Dose_CherryPick [AID463229, Type: confirmatory] | |  View X | Row No. | 9 | | Structure |
| | Substance | | | SID | 47201770 | | CID | 23724261 | | Outcome | Active | | AC50 | 3.218 [uM] | | BioAssay | ATP-based Luminescence in the Absence of Cytokines Measured in Cell-Based System Using Plate Reader - 2061-06_Inhibitor_Dose_CherryPick | | AID | 463229 | | BioAssay type | confirmatory | | Target | | | PubMed | | | Data Table |  |
|
| 10 | [SID47201770] | Active | Potency | 5.6234 | CHOP2 Reporter Counterscreen Assay for Inhibitors of Ubiquitin-specific Protease USP2a [AID493169, Type: confirmatory] | enteropeptidase precursor [Homo sapiens] [gi:223942069] |  View X | Row No. | 10 | | Structure |
| | Substance | | | SID | 47201770 | | CID | 23724261 | | Outcome | Active | | Potency | 5.6234 [uM] | | BioAssay | CHOP2 Reporter Counterscreen Assay for Inhibitors of Ubiquitin-specific Protease USP2a | | AID | 493169 | | BioAssay type | confirmatory | | Target | enteropeptidase precursor [Homo sapiens] [gi:223942069] | | PubMed | | | Data Table |  |
|
| 11 | [SID47201770] | Active | AC50 | 6.929 | Fluorescence Cell-Free Homogeneous Secondary Screen to Identify Non-Covalent Inhibitors of RecA-Intein Splicing Activity [AID449750, Type: confirmatory] | replicative DNA helicase [Mycobacterium tuberculosis H37Rv] [gi:15607200] |  View X | Row No. | 11 | | Structure |
| | Substance | | | SID | 47201770 | | CID | 23724261 | | Outcome | Active | | AC50 | 6.929 [uM] | | BioAssay | Fluorescence Cell-Free Homogeneous Secondary Screen to Identify Non-Covalent Inhibitors of RecA-Intein Splicing Activity | | AID | 449750 | | BioAssay type | confirmatory | | Target | replicative DNA helicase [Mycobacterium tuberculosis H37Rv] [gi:15607200] | | PubMed | | | Data Table |  |
|
| 12 | [SID47201770] | Active | EC50 | 7.26 | Fluorescence Cell-Free Homogeneous Dose Retest to Identify Inhibitors of RecA-Intein Splicing Activity [AID435010, Type: confirmatory] | DNA recombination protein RecA [Mycobacterium tuberculosis H37Rv] [gi:15609874] |  View X | Row No. | 12 | | Structure |
| | Substance | | | SID | 47201770 | | CID | 23724261 | | Outcome | Active | | EC50 | 7.26 [uM] | | BioAssay | Fluorescence Cell-Free Homogeneous Dose Retest to Identify Inhibitors of RecA-Intein Splicing Activity | | AID | 435010 | | BioAssay type | confirmatory | | Target | DNA recombination protein RecA [Mycobacterium tuberculosis H37Rv] [gi:15609874] | | PubMed | | | Data Table |  |
|
| 13 | [SID47201770] | Active | EC50 | 7.573 | Fluorescence Cell-Free Homogeneous Counter Screen to Identify Inhibitors of GFP Chromophore Formation [AID434968, Type: confirmatory] | DNA recombination protein RecA [Mycobacterium tuberculosis H37Rv] [gi:15609874] |  View X | Row No. | 13 | | Structure |
| | Substance | | | SID | 47201770 | | CID | 23724261 | | Outcome | Active | | EC50 | 7.573 [uM] | | BioAssay | Fluorescence Cell-Free Homogeneous Counter Screen to Identify Inhibitors of GFP Chromophore Formation | | AID | 434968 | | BioAssay type | confirmatory | | Target | DNA recombination protein RecA [Mycobacterium tuberculosis H37Rv] [gi:15609874] | | PubMed | | | Data Table |  |
|
| 14 | [SID47201770] | Active | IC50 | 8.53 | Dose response confirmation of uHTS hits for Apaf-1 in a Fluorescent assay [AID588524, Type: confirmatory] | Apoptotic peptidase activating factor 1 [Homo sapiens] [gi:187952397] |  View X | Row No. | 14 | | Structure |
| | Substance | | | SID | 47201770 | | CID | 23724261 | | Outcome | Active | | IC50 | 8.53 [uM] | | BioAssay | Dose response confirmation of uHTS hits for Apaf-1 in a Fluorescent assay | | AID | 588524 | | BioAssay type | confirmatory | | Target | Apoptotic peptidase activating factor 1 [Homo sapiens] [gi:187952397] | | PubMed | | | Data Table |  |
|
| 15 | [SID47201770] | Active | AC50 | 8.723 | Ras-converting Enzyme/Cell Proliferation Pathway Measured in Biochemical System Using Plate Reader - 2034-01_Inhibitor_Dose_CherryPick [AID488788, Type: confirmatory] | Rce1p [Saccharomyces cerevisiae S288c] [gi:6323930] |  View X | Row No. | 15 | | Structure |
| | Substance | | | SID | 47201770 | | CID | 23724261 | | Outcome | Active | | AC50 | 8.723 [uM] | | BioAssay | Ras-converting Enzyme/Cell Proliferation Pathway Measured in Biochemical System Using Plate Reader - 2034-01_Inhibitor_Dose_CherryPick | | AID | 488788 | | BioAssay type | confirmatory | | Target | Rce1p [Saccharomyces cerevisiae S288c] [gi:6323930] | | PubMed | | | Data Table |  |
|
| 16 | [SID47201770] | Active | AC50 | 8.723 | Ras-converting Enzyme/Cell Proliferation Pathway Measured in Biochemical System Using Plate Reader - 2034-01_Inhibitor_Dose_CherryPick [AID488788, Type: confirmatory] | Rce1p [Saccharomyces cerevisiae S288c] [gi:6323930] |  View X | Row No. | 16 | | Structure |
| | Substance | | | SID | 47201770 | | CID | 23724261 | | Outcome | Active | | AC50 | 8.723 [uM] | | BioAssay | Ras-converting Enzyme/Cell Proliferation Pathway Measured in Biochemical System Using Plate Reader - 2034-01_Inhibitor_Dose_CherryPick | | AID | 488788 | | BioAssay type | confirmatory | | Target | Rce1p [Saccharomyces cerevisiae S288c] [gi:6323930] | | PubMed | | | Data Table |  |
|
| 17 | [SID47201770] | Active | Potency | 8.9125 | qHTS for Inhibitors of binding or entry into cells for Lassa Virus [AID540256, Type: confirmatory] | |  View X | Row No. | 17 | | Structure |
| | Substance | | | SID | 47201770 | | CID | 23724261 | | Outcome | Active | | Potency | 8.9125 [uM] | | BioAssay | qHTS for Inhibitors of binding or entry into cells for Lassa Virus | | AID | 540256 | | BioAssay type | confirmatory | | Target | | | PubMed | | | Data Table |  |
|
| 18 | [SID47201770] | Active | IC50 | 10.42 | A counter screen for small molecule screen for inhibitors of the PhoP regulon in Salmonella typhi [AID2384, Type: confirmatory] | |  View X | Row No. | 18 | | Structure |
| | Substance | | | SID | 47201770 | | CID | 23724261 | | Outcome | Active | | IC50 | 10.42 [uM] | | BioAssay | A counter screen for small molecule screen for inhibitors of the PhoP regulon in Salmonella typhi | | AID | 2384 | | BioAssay type | confirmatory | | Target | | | PubMed | | | Data Table |  |
|
| 19 | [SID47201770] | Active | Potency | 11.5821 | qHTS for induction of synthetic lethality in tumor cells producing 2HG: qHTS for the HT-1080-IDH1KD cell line [AID686971, Type: confirmatory] | |  View X | Row No. | 19 | | Structure |
| | Substance | | | SID | 47201770 | | CID | 23724261 | | Outcome | Active | | Potency | 11.5821 [uM] | | BioAssay | qHTS for induction of synthetic lethality in tumor cells producing 2HG: qHTS for the HT-1080-IDH1KD cell line | | AID | 686971 | | BioAssay type | confirmatory | | Target | | | PubMed | | | Data Table |  |
|
| 20 | [SID47201770] | Active | IC50 | 12.1 | Dose response confirmation of uHTS hits for Apaf-1 using a LZ-Caspase-9/Caspase-3 Fluorescent Selectivity assay [AID588574, Type: confirmatory] | CASP3 gene product [Homo sapiens] [gi:14790119] |  View X | Row No. | 20 | | Structure |
| | Substance | | | SID | 47201770 | | CID | 23724261 | | Outcome | Active | | IC50 | 12.1 [uM] | | BioAssay | Dose response confirmation of uHTS hits for Apaf-1 using a LZ-Caspase-9/Caspase-3 Fluorescent Selectivity assay | | AID | 588574 | | BioAssay type | confirmatory | | Target | CASP3 gene product [Homo sapiens] [gi:14790119] | | PubMed | | | Data Table |  |
|
| 21 | [SID47201770] | Active | IC50 | 12.1 | Dose response confirmation of uHTS hits for Apaf-1 using a LZ-Caspase-9/Caspase-3 Fluorescent Selectivity assay [AID588574, Type: confirmatory] | CASP3 gene product [Homo sapiens] [gi:14790119] |  View X | Row No. | 21 | | Structure |
| | Substance | | | SID | 47201770 | | CID | 23724261 | | Outcome | Active | | IC50 | 12.1 [uM] | | BioAssay | Dose response confirmation of uHTS hits for Apaf-1 using a LZ-Caspase-9/Caspase-3 Fluorescent Selectivity assay | | AID | 588574 | | BioAssay type | confirmatory | | Target | CASP3 gene product [Homo sapiens] [gi:14790119] | | PubMed | | | Data Table |  |
|
| 22 | [SID47201770] | Active | IC50 | 12.1 | Dose response confirmation of uHTS hits for Apaf-1 using a LZ-Caspase-9/Caspase-3 Fluorescent Selectivity assay [AID588574, Type: confirmatory] | CASP3 gene product [Homo sapiens] [gi:14790119] |  View X | Row No. | 22 | | Structure |
| | Substance | | | SID | 47201770 | | CID | 23724261 | | Outcome | Active | | IC50 | 12.1 [uM] | | BioAssay | Dose response confirmation of uHTS hits for Apaf-1 using a LZ-Caspase-9/Caspase-3 Fluorescent Selectivity assay | | AID | 588574 | | BioAssay type | confirmatory | | Target | CASP3 gene product [Homo sapiens] [gi:14790119] | | PubMed | | | Data Table |  |
|
| 23 | [SID47201770] | Active | IC50 | 12.1 | Dose response confirmation of uHTS hits for Apaf-1 using a LZ-Caspase-9/Caspase-3 Fluorescent Selectivity assay [AID588574, Type: confirmatory] | CASP3 gene product [Homo sapiens] [gi:14790119] |  View X | Row No. | 23 | | Structure |
| | Substance | | | SID | 47201770 | | CID | 23724261 | | Outcome | Active | | IC50 | 12.1 [uM] | | BioAssay | Dose response confirmation of uHTS hits for Apaf-1 using a LZ-Caspase-9/Caspase-3 Fluorescent Selectivity assay | | AID | 588574 | | BioAssay type | confirmatory | | Target | CASP3 gene product [Homo sapiens] [gi:14790119] | | PubMed | | | Data Table |  |
|
| 24 | [SID47201770] | Active | IC50 | 13.2 | A small molecule screen for inhibitors of the PhoP regulon in Salmonella typhi [AID1850, Type: confirmatory] | |  View X | Row No. | 24 | | Structure |
| | Substance | | | SID | 47201770 | | CID | 23724261 | | Outcome | Active | | IC50 | 13.2 [uM] | | BioAssay | A small molecule screen for inhibitors of the PhoP regulon in Salmonella typhi | | AID | 1850 | | BioAssay type | confirmatory | | Target | | | PubMed | | | Data Table |  |
|
| 25 | [SID47201770] | Active | Potency | 15.8489 | VP16 counterscreen qHTS for inhibitors of ROR gamma transcriptional activity [AID2546, Type: confirmatory] | nuclear receptor ROR-gamma [Mus musculus] [gi:188536040] |  View X | Row No. | 25 | | Structure |
| | Substance | | | SID | 47201770 | | CID | 23724261 | | Outcome | Active | | Potency | 15.8489 [uM] | | BioAssay | VP16 counterscreen qHTS for inhibitors of ROR gamma transcriptional activity | | AID | 2546 | | BioAssay type | confirmatory | | Target | nuclear receptor ROR-gamma [Mus musculus] [gi:188536040] | | PubMed | | | Data Table |  |
|
| 26 | [SID47201770] | Active | IC50 | 21.313 | A screen for inhibitors of the PhoP regulon in Salmonella Typhi using a modified counterscreen [AID1985, Type: confirmatory] | |  View X | Row No. | 26 | | Structure |
| | Substance | | | SID | 47201770 | | CID | 23724261 | | Outcome | Active | | IC50 | 21.313 [uM] | | BioAssay | A screen for inhibitors of the PhoP regulon in Salmonella Typhi using a modified counterscreen | | AID | 1985 | | BioAssay type | confirmatory | | Target | | | PubMed | | | Data Table |  |
|
| 27 | [SID47201770] | Active | Potency | 23.1093 | qHTS for induction of synthetic lethality in tumor cells producing 2HG: qHTS for the HT-1080-NT fibrosarcoma cell line [AID686970, Type: confirmatory] | IDH1 [Homo sapiens] [gi:49168486] |  View X | Row No. | 27 | | Structure |
| | Substance | | | SID | 47201770 | | CID | 23724261 | | Outcome | Active | | Potency | 23.1093 [uM] | | BioAssay | qHTS for induction of synthetic lethality in tumor cells producing 2HG: qHTS for the HT-1080-NT fibrosarcoma cell line | | AID | 686970 | | BioAssay type | confirmatory | | Target | IDH1 [Homo sapiens] [gi:49168486] | | PubMed | | | Data Table |  |
|
| 28 | [SID47201770] | Active | Potency | 25.1189 | qHTS for inhibitors of binding or entry into cells for Marburg Virus [AID540276, Type: confirmatory] | gene 4 small orf - Marburg virus [gi:420597] |  View X | Row No. | 28 | | Structure |
| | Substance | | | SID | 47201770 | | CID | 23724261 | | Outcome | Active | | Potency | 25.1189 [uM] | | BioAssay | qHTS for inhibitors of binding or entry into cells for Marburg Virus | | AID | 540276 | | BioAssay type | confirmatory | | Target | gene 4 small orf - Marburg virus [gi:420597] | | PubMed | | | Data Table |  |
|
| 29 | [SID47201770] | Active | Potency | 44.6684 | qHTS Assay for Inhibitors of Bacillus subtilis Sfp phosphopantetheinyl transferase (PPTase) [AID1490, Type: confirmatory] | phosphopantetheinyl transferase [Bacillus subtilis] [gi:10954339] |  View X | Row No. | 29 | | Structure |
| | Substance | | | SID | 47201770 | | CID | 23724261 | | Outcome | Active | | Potency | 44.6684 [uM] | | BioAssay | qHTS Assay for Inhibitors of Bacillus subtilis Sfp phosphopantetheinyl transferase (PPTase) | | AID | 1490 | | BioAssay type | confirmatory | | Target | phosphopantetheinyl transferase [Bacillus subtilis] [gi:10954339] | | PubMed | | | Data Table |  |
|
| 30 | [SID47201770] | Active | | | HTS for Beta-2AR agonists via FAP method [AID504454, Type: screening] | ADRB2 gene product [Homo sapiens] [gi:4501969] |  View X | Row No. | 30 | | Structure |
| | Substance | | | SID | 47201770 | | CID | 23724261 | | Outcome | Active | | BioAssay | HTS for Beta-2AR agonists via FAP method | | AID | 504454 | | BioAssay type | screening | | Target | ADRB2 gene product [Homo sapiens] [gi:4501969] | | PubMed | | | Data Table |  |
|
| 31 | [SID47201770] | Active | | | HTS for Beta-2AR agonists via FAP method [AID504454, Type: screening] | ADRB2 gene product [Homo sapiens] [gi:4501969] |  View X | Row No. | 31 | | Structure |
| | Substance | | | SID | 47201770 | | CID | 23724261 | | Outcome | Active | | BioAssay | HTS for Beta-2AR agonists via FAP method | | AID | 504454 | | BioAssay type | screening | | Target | ADRB2 gene product [Homo sapiens] [gi:4501969] | | PubMed | | | Data Table |  |
|
| 32 | [SID47201770] | Active | | | HTS for Beta-2AR agonists via FAP method [AID504454, Type: screening] | ADRB2 gene product [Homo sapiens] [gi:4501969] |  View X | Row No. | 32 | | Structure |
| | Substance | | | SID | 47201770 | | CID | 23724261 | | Outcome | Active | | BioAssay | HTS for Beta-2AR agonists via FAP method | | AID | 504454 | | BioAssay type | screening | | Target | ADRB2 gene product [Homo sapiens] [gi:4501969] | | PubMed | | | Data Table |  |
|
| 33 | [SID47201770] | Active | | | HTS for Beta-2AR agonists via FAP method [AID504454, Type: screening] | ADRB2 gene product [Homo sapiens] [gi:4501969] |  View X | Row No. | 33 | | Structure |
| | Substance | | | SID | 47201770 | | CID | 23724261 | | Outcome | Active | | BioAssay | HTS for Beta-2AR agonists via FAP method | | AID | 504454 | | BioAssay type | screening | | Target | ADRB2 gene product [Homo sapiens] [gi:4501969] | | PubMed | | | Data Table |  |
|
| 34 | [SID47201770] | Active | | | MLPCN ERAP1 Measured in Biochemical System Using Plate Reader - 7016-01_Inhibitor_SinglePoint_HTS_Activity [AID652197, Type: screening] | |  View X | Row No. | 34 | | Structure |
| | Substance | | | SID | 47201770 | | CID | 23724261 | | Outcome | Active | | BioAssay | MLPCN ERAP1 Measured in Biochemical System Using Plate Reader - 7016-01_Inhibitor_SinglePoint_HTS_Activity | | AID | 652197 | | BioAssay type | screening | | Target | | | PubMed | | | Data Table |  |
|
| 35 | [SID47201770] | Active | | | Luminescence Cell-Based/Microorganism Primary HTS to Identify Inhibitors of T.Cruzi Replication [AID1885, Type: screening] | |  View X | Row No. | 35 | | Structure |
| | Substance | | | SID | 47201770 | | CID | 23724261 | | Outcome | Active | | BioAssay | Luminescence Cell-Based/Microorganism Primary HTS to Identify Inhibitors of T.Cruzi Replication | | AID | 1885 | | BioAssay type | screening | | Target | | | PubMed | | | Data Table |  |
|
| 36 | [SID47201770] | Active | | | Luminescence Cell-Based Primary HTS to Identify Inhibitors of Beta Cell Apoptosis. [AID435005, Type: screening] | |  View X | Row No. | 36 | | Structure |
| | Substance | | | SID | 47201770 | | CID | 23724261 | | Outcome | Active | | BioAssay | Luminescence Cell-Based Primary HTS to Identify Inhibitors of Beta Cell Apoptosis. | | AID | 435005 | | BioAssay type | screening | | Target | | | PubMed | | | Data Table |  |
|
| 37 | [SID47201770] | Active | | | Luminescence Cell-Based Primary HTS to Identify Inhibitors of Cancer Stem Cells [AID2717, Type: screening] | |  View X | Row No. | 37 | | Structure |
| | Substance | | | SID | 47201770 | | CID | 23724261 | | Outcome | Active | | BioAssay | Luminescence Cell-Based Primary HTS to Identify Inhibitors of Cancer Stem Cells | | AID | 2717 | | BioAssay type | screening | | Target | | | PubMed | | | Data Table |  |
|
| 38 | [SID47201770] | Active | | | Single concentration confirmation of small molecule activators of the adaptive arm of the Unfolded Protein response via a luminescent-based reporter assay [AID485299, Type: screening] | |  View X | Row No. | 38 | | Structure |
| | Substance | | | SID | 47201770 | | CID | 23724261 | | Outcome | Active | | BioAssay | Single concentration confirmation of small molecule activators of the adaptive arm of the Unfolded Protein response via a luminescent-based reporter assay | | AID | 485299 | | BioAssay type | screening | | Target | | | PubMed | | | Data Table |  |
|
| 39 | [SID47201770] | Active | | | uHTS identification of small molecule activators of the adaptive arm of the Unfolded Protein response via a luminescent-based reporter assay [AID463104, Type: screening] | |  View X | Row No. | 39 | | Structure |
| | Substance | | | SID | 47201770 | | CID | 23724261 | | Outcome | Active | | BioAssay | uHTS identification of small molecule activators of the adaptive arm of the Unfolded Protein response via a luminescent-based reporter assay | | AID | 463104 | | BioAssay type | screening | | Target | | | PubMed | | | Data Table |  |
|
| 40 | [SID47201770] | Active | | | Fluorescence-based counterscreen for orexin 1 receptor (OX1R) antagonists: cell-based assay to identify antagonists of the parental CHO cell line [AID463079, Type: screening] | |  View X | Row No. | 40 | | Structure |
| | Substance | | | SID | 47201770 | | CID | 23724261 | | Outcome | Active | | BioAssay | Fluorescence-based counterscreen for orexin 1 receptor (OX1R) antagonists: cell-based assay to identify antagonists of the parental CHO cell line | | AID | 463079 | | BioAssay type | screening | | Target | | | PubMed | | | Data Table |  |
|
| 41 | [SID47201770] | Active | | | Flow Cytometric HTS Screening for Inhibitors of Lytic Granule Exocytosis with MLPCN Compound Library [AID651702, Type: screening] | |  View X | Row No. | 41 | | Structure |
| | Substance | | | SID | 47201770 | | CID | 23724261 | | Outcome | Active | | BioAssay | Flow Cytometric HTS Screening for Inhibitors of Lytic Granule Exocytosis with MLPCN Compound Library | | AID | 651702 | | BioAssay type | screening | | Target | | | PubMed | | | Data Table |  |
|
| 42 | [SID47201770] | Active | | | uHTS identification of cystic fibrosis induced NFkb Inhibitors in a fluoresence assay [AID588850, Type: screening] | CFTR gene product [Homo sapiens] [gi:90421313] |  View X | Row No. | 42 | | Structure |
| | Substance | | | SID | 47201770 | | CID | 23724261 | | Outcome | Active | | BioAssay | uHTS identification of cystic fibrosis induced NFkb Inhibitors in a fluoresence assay | | AID | 588850 | | BioAssay type | screening | | Target | CFTR gene product [Homo sapiens] [gi:90421313] | | PubMed | | | Data Table |  |
|
| 43 | [SID47201770] | Active | | | uHTS identification of cystic fibrosis induced NFkb Inhibitors in a fluoresence assay [AID588850, Type: screening] | CFTR gene product [Homo sapiens] [gi:90421313] |  View X | Row No. | 43 | | Structure |
| | Substance | | | SID | 47201770 | | CID | 23724261 | | Outcome | Active | | BioAssay | uHTS identification of cystic fibrosis induced NFkb Inhibitors in a fluoresence assay | | AID | 588850 | | BioAssay type | screening | | Target | CFTR gene product [Homo sapiens] [gi:90421313] | | PubMed | | | Data Table |  |
|
| 44 | [SID47201770] | Active | | | Single concentration confirmation of uHTS Fluorescent assay for identification of inhibitors of Apaf-1 [AID504614, Type: screening] | Apoptotic peptidase activating factor 1 [Homo sapiens] [gi:187952397] |  View X | Row No. | 44 | | Structure |
| | Substance | | | SID | 47201770 | | CID | 23724261 | | Outcome | Active | | BioAssay | Single concentration confirmation of uHTS Fluorescent assay for identification of inhibitors of Apaf-1 | | AID | 504614 | | BioAssay type | screening | | Target | Apoptotic peptidase activating factor 1 [Homo sapiens] [gi:187952397] | | PubMed | | | Data Table |  |
|
| 45 | [SID47201770] | Active | | | uHTS Fluorescent assay for identification of inhibitors of Apaf-1 [AID489030, Type: screening] | Apoptotic peptidase activating factor 1 [Homo sapiens] [gi:187952397] |  View X | Row No. | 45 | | Structure |
| | Substance | | | SID | 47201770 | | CID | 23724261 | | Outcome | Active | | BioAssay | uHTS Fluorescent assay for identification of inhibitors of Apaf-1 | | AID | 489030 | | BioAssay type | screening | | Target | Apoptotic peptidase activating factor 1 [Homo sapiens] [gi:187952397] | | PubMed | | | Data Table |  |
|
| 46 | [SID47201770] | Active | | | Fluorescence-based cell-based primary high throughput screening assay to identify antagonists of the human cholinergic receptor, muscarinic 4 (CHRM4) [AID624125, Type: screening] | CHRM4 gene product [Homo sapiens] [gi:52426748] |  View X | Row No. | 46 | | Structure |
| | Substance | | | SID | 47201770 | | CID | 23724261 | | Outcome | Active | | BioAssay | Fluorescence-based cell-based primary high throughput screening assay to identify antagonists of the human cholinergic receptor, muscarinic 4 (CHRM4) | | AID | 624125 | | BioAssay type | screening | | Target | CHRM4 gene product [Homo sapiens] [gi:52426748] | | PubMed | | | Data Table |  |
|
| 47 | [SID47201770] | Active | | | Fluorescence-based cell-based primary high throughput screening assay to identify antagonists of the human cholinergic receptor, muscarinic 4 (CHRM4) [AID624125, Type: screening] | CHRM4 gene product [Homo sapiens] [gi:52426748] |  View X | Row No. | 47 | | Structure |
| | Substance | | | SID | 47201770 | | CID | 23724261 | | Outcome | Active | | BioAssay | Fluorescence-based cell-based primary high throughput screening assay to identify antagonists of the human cholinergic receptor, muscarinic 4 (CHRM4) | | AID | 624125 | | BioAssay type | screening | | Target | CHRM4 gene product [Homo sapiens] [gi:52426748] | | PubMed | | | Data Table |  |
|
| 48 | [SID47201770] | Active | | | Fluorescence-based cell-based primary high throughput screening assay to identify antagonists of the human cholinergic receptor, muscarinic 4 (CHRM4) [AID624125, Type: screening] | CHRM4 gene product [Homo sapiens] [gi:52426748] |  View X | Row No. | 48 | | Structure |
| | Substance | | | SID | 47201770 | | CID | 23724261 | | Outcome | Active | | BioAssay | Fluorescence-based cell-based primary high throughput screening assay to identify antagonists of the human cholinergic receptor, muscarinic 4 (CHRM4) | | AID | 624125 | | BioAssay type | screening | | Target | CHRM4 gene product [Homo sapiens] [gi:52426748] | | PubMed | | | Data Table |  |
|
| 49 | [SID47201770] | Active | | | Fluorescence-based cell-based primary high throughput screening assay to identify antagonists of the human cholinergic receptor, muscarinic 5 (CHRM5) [AID624040, Type: screening] | CHRM5 gene product [Homo sapiens] [gi:7108336] |  View X | Row No. | 49 | | Structure |
| | Substance | | | SID | 47201770 | | CID | 23724261 | | Outcome | Active | | BioAssay | Fluorescence-based cell-based primary high throughput screening assay to identify antagonists of the human cholinergic receptor, muscarinic 5 (CHRM5) | | AID | 624040 | | BioAssay type | screening | | Target | CHRM5 gene product [Homo sapiens] [gi:7108336] | | PubMed | | | Data Table |  |
|
| 50 | [SID47201770] | Active | | | Fluorescence-based cell-based primary high throughput screening assay to identify antagonists of the human cholinergic receptor, muscarinic 5 (CHRM5) [AID624040, Type: screening] | CHRM5 gene product [Homo sapiens] [gi:7108336] |  View X | Row No. | 50 | | Structure |
| | Substance | | | SID | 47201770 | | CID | 23724261 | | Outcome | Active | | BioAssay | Fluorescence-based cell-based primary high throughput screening assay to identify antagonists of the human cholinergic receptor, muscarinic 5 (CHRM5) | | AID | 624040 | | BioAssay type | screening | | Target | CHRM5 gene product [Homo sapiens] [gi:7108336] | | PubMed | | | Data Table |  |
|